| Exploitation of a very small peptide nucleic acid as a new inhibitor of miR-509-3p involved in the regulation of cystic fibrosis disease-gene expression F Amato, R Tomaiuolo, F Nici, N Borbone, A Elce, B Catalanotti, S D'Errico, ... BioMed research international 2014, 2014 | 54 | 2014 |
| Peptide nucleic acids as miRNA target protectors for the treatment of cystic fibrosis F Zarrilli, F Amato, CM Morgillo, B Pinto, G Santarpia, N Borbone, ... Molecules 22 (7), 1144, 2017 | 40 | 2017 |
| Interaction of the N-(3-Methylpyridin-2-yl)amide Derivatives of Flurbiprofen and Ibuprofen with FAAH: Enantiomeric Selectivity and Binding Mode J Karlsson, CM Morgillo, A Deplano, G Smaldone, E Pedone, FJ Luque, ... PLoS One 10 (11), e0142711, 2015 | 16 | 2015 |
| Novel propanamides as fatty acid amide hydrolase inhibitors A Deplano, CM Morgillo, M Demurtas, E Björklund, M Cipriano, ... European Journal of Medicinal Chemistry 136, 523-542, 2017 | 11 | 2017 |
| Structural Model of the hUbA1-UbcH10 Quaternary Complex: In Silico and Experimental Analysis of the Protein-Protein Interactions between E1, E2 and Ubiquitin S Correale, I de Paola, CM Morgillo, A Federico, L Zaccaro, P Pallante, ... Plos one 9 (11), e112082, 2014 | 11 | 2014 |
| Identification of a proteasome-targeting arylsulfonamide with potential for the treatment of Chagas’ disease ML Lima, LB Tulloch, V Corpas-Lopez, S Carvalho, RJ Wall, R Milne, ... Antimicrobial agents and chemotherapy 66 (1), e01535-21, 2022 | 10 | 2022 |
| Design, synthesis and in vitro and in vivo biological evaluation of flurbiprofen amides as new fatty acid amide hydrolase/cyclooxygenase-2 dual inhibitory potential … A Deplano, J Karlsson, F Moraca, M Svensson, C Cristiano, CM Morgillo, ... Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 940-953, 2021 | 4 | 2021 |
| Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition CM Morgillo, A Lupia, A Deplano, L Pirone, B Fiorillo, E Pedone, ... International Journal of Molecular Sciences 23 (24), 15502, 2022 | 1 | 2022 |
| Exploring the DNA2-PNA heterotriplex formation in targeting the Bcl-2 gene promoter: A structural insight by physico-chemical and microsecond-scale MD investigation AP Falanga, A Lupia, L Tripodi, CM Morgillo, F Moraca, GN Roviello, ... Heliyon 10 (3), 2024 | | 2024 |
| Design and pharmacological evaluation of Ibuprofen amides derivatives as dual FAAH/COX inhibitors F Moraca, C Morgillo, A Deplano, E Novellino, V Onnis, C Fowler, ... Design and pharmacological evaluation of Ibuprofen amides derivatives as …, 2019 | | 2019 |
| Target Protector PNA: a new tool in Cystic Fibrosis treatment B Pinto, G Oliviero, N Borbone, S D’Errico, F Nici, G Santarpia, C Morgillo, ... | | 2016 |
| Discovery of a novel class of profen derivatives as FAAH inhibitors: MD and QM/MM studies of the binding mode and 3D SAR CM Morgillo, A Deplano, J Karlsson, M Svensson, A Björklund, CJ Fowler, ... EuroQSAR 2016 Abstract Book, 2016 | | 2016 |
| Investigation of the mechanism of FAAH inhibition of profen amide derivatives C Morgillo, A Deplano, M Demurtas, J Karlosson, V Onnis, C Congiu, ... XXIII National Meeting on Medicinal Chemistry Abstract Book, 95-95, 2015 | | 2015 |
| Design, synthesis and pharmacological investigation on new FAAH inhibitors V ONNIS, C CONGIU, A DEPLANO, M Demurtas, M Cipriano, ... CHEMMEDCHEM, 429-429, 2014 | | 2014 |
| Homology building, protein-protein docking and MD approach to the simulation of the quaternary complex E1/E2/Ub2 CM Morgillo, E Stendardo, A Galeone, B Catalanotti | | 2012 |
| From protein-protein interaction to E2 inhibitors leads: identification of peptide binding of UbcH10 CM Morgillo, S Correale, A Federico, I DE PAOLA, F Forti, L Zaccaro, ... | | 2012 |
Bruno CatalanottiRicercatore in Chimica Farmaceutica, Università degli Studi di Napoli Federico IIVerified email at unina.it
